Actinogen Medical Ltd (ACW) — Cash Flow Reinvestment Rate
Latest as of December 2024:
0.00x
Actinogen Medical Ltd (ACW) has a Cash Flow Reinvestment Rate of 0.00x as of December 2024, reinvesting AU$2.36K (capex AU$2.36K ) from operating cash flow of AU$1.74 Million. Explore Actinogen Medical Ltd cash conversion from operations to assess how effectively this company generates cash.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
AU$2.36K
Capex + Investments
Operating Cash Flow
AU$1.74 Million
AUD
Capital Expenditures
AU$2.36K
AUD
Annual Cash Flow Reinvestment Rate for Actinogen Medical Ltd (None–None)
Year-by-year capital reinvestment analysis for Actinogen Medical Ltd. For live market cap and broader valuation context, see ACW stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (AUD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow